CCL5 and cancer: Since CCL5 is an inflammatory cytokine which increases tumor growth, induces extracellular matrix remodeling, and enhances tumor cell migration [14], its decrease is in line with the remarkable anti-inflammatory effect of MSCs [19], suggesting that tumor-naïve MSCs can slow down cancer progression by altering the inflammatory TME.